Fundz

Biotherapeutic Targeting Firm Ability Biologics Lands $12M Seed

PRIVATEDec 07, 2023

Amount Raised

$12 Million

Round Type

Seed

MontrealBiotechnology

Investors

Amplitude Ventures

Description

Ability Biologics, a Montreal, Canada-based premier cell targeting company, closed a $12m financing round.

Quick answer

Ability Biologics raised $12 Million in a Seed round, dated December 7, 2023. Investors: Amplitude Ventures. Ability Biologics is based in Montreal, Quebec, Canada.

How much did Ability Biologics raise?
Ability Biologics raised $12 Million in a Seed round on December 7, 2023.
Who invested in Ability Biologics?
Amplitude Ventures is named as investors in this round.
What does Ability Biologics do?
Ability Biotherapeutics is the next-generation biotherapeutics company developing logic-gated antibodies with exceptional contextual selectivity and stability, driving safer, more effective immunotherapies for cancer..
Where is Ability Biologics based and how big is it?
Ability Biologics is based in Montreal, Quebec, Canada.
Who are the decision-makers at Ability Biologics?
Fundz holds 1 contact at Ability Biologics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Ability Biologics that raised within 45 days of this round, from Fundz verified event records.

  • Sanuwave raised $4.6M (Seed) on January 21, 2024.
  • EnteroBiotix raised $2.6M (Seed) on January 19, 2024.
  • View Point Medical raised $3.8M (Seed) on January 19, 2024.
  • Entact Bio raised $40M on January 19, 2024.
  • Epicore Biosystems raised $26M (Series A) on January 19, 2024.
  • FOXO Technologies raised $3.5M on January 19, 2024.

Who to call at Ability Biologics, and when

A new round usually means Ability Biologics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ability Biologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ability Biologics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ability Biologics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ability Biologics

Location

Montreal, Quebec, Canada

About

Ability Biotherapeutics is the next-generation biotherapeutics company developing logic-gated antibodies with exceptional contextual selectivity and stability, driving safer, more effective immunotherapies for cancer and autoimmune diseases. Its proprietary platform, AbiLeap™, uses generative AI powered by one of the largest and exclusively held, therapeutically relevant human antibody databases, providing distinct insights for sequence space exploration. Combining AI with in vitro display and screening technologies, AbiLeap™ generates fully human antibodies that are conditionally activated and multi-specific, directing therapeutic targeting to specific cells and disease sites. This approach enables solutions for indications with high unmet clinical needs by reducing toxicity and significantly broadening the therapeutic window, maximizing treatment benefits.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ability Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Ability Biologics's next move

See what Strategic adds

Ability Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.